Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions

Abstract

BackgroundLittle is known about weekly variability in medication nonadherence both between and within persons.PurposeTo characterize medication nonadherence across repeated, closely spaced occasions.MethodsThis prospective cohort study comprised four unannounced telephone assessment occasions, each separated by approximately 2 weeks. On each occasion, adult outpatients taking at least a single antihypertensive medication completed a measure of extent of, and reasons for, nonadherence.ResultsTwo hundred and sixty-one participants completed 871 (83%) of 1,044 occasions. Nonadherence was reported on 152 (17.5%) of 871 occasions by 93 (36%) of 261 participants. The most commonly endorsed reasons for nonadherence were forgetting (39.5%), being busy (23.7%), and traveling (19.7%). Among 219 participants completing at least three occasions, 50% of the variability in extent of nonadherence was a result of within-person fluctuations, and 50% was a result of between-person differences.ConclusionInterventions to reduce nonadherence should be informed by variability in the extent of nonadherence and specific reasons for nonadherence.

Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study

“…However, depressive symptoms and social support were not associated with non-adherence in the current study. It is possible that the factors influencing medication non-adherence in the previous 24 hours differ from the factors that contribute to usual patterns of non-adherence over weeks and months (33). …”

Patient‐reported outcomes in the Translational Breast Cancer Research Consortium

“…As seen in Table , we identified 22 domains to form the basis of our guide. These ranged from health‐related QOL, a very general measure that can be used for patients with multiple cancer sites and stages; to lymphedema, which often is used specifically with patients who have undergone breast surgery; to financial toxicity, a recently identified domain with which to assess the financial and resource‐related difficulties experienced by patients with cancer.…”

Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment

“…The VMAS consists of 3 patient-reported items that evaluated the extent of adherence using a 5-point Likert scale from 1=None of the time to 5=All of the time 51,52 . The items ask the participants how often they have missed doses over the past 7 days, averaged into a single score shown to be reliable (alpha = 0.84).…”